Lin H J, Haywood M, Hollinger F B
Division of Molecular Virology, Baylor College of Medicine, Houston, Texas 77030, USA.
J Clin Microbiol. 1996 Feb;34(2):329-33. doi: 10.1128/jcm.34.2.329-333.1996.
Quantitative tests for human immunodeficiency virus type 1 (HIV-1) RNA in plasma and proviral DNA in peripheral blood mononuclear cells (PBMC) provide valuable information on the status of HIV-1 infection. This paper describes tests that were carried out with commercially available materials and an enzyme-linked immunosorbent assay reader for detecting spectrophotometric changes. Samples consisted of 100 microliters of plasma or 200,000 PBMC. The procedure involved sample preparation, PCR-based amplification with the primer pair SK39 (biotinylated at the 5' end) and SK38, hybridization of the cDNA PCR product to an RNA probe, capture of the RNA-DNA hybrid on a solid phase by means of strepavidin, binding to an alkaline phosphatase-conjugated antibody directed against RNA-DNA hybrids, and incubation with p-nitrophenylphosphate. Spectrophotometric changes were recorded at four intervals over a period of 20 h. The inclusion of HIV-1 RNA or proviral DNA standards in each run was an integral part of the procedure. The dynamic ranges afforded by these assays--500 to 1 million RNA copies per ml and 10 to 5,000 proviral DNA copies per 10(6) PBMC--were applicable to most plasma specimens and to all PBMC specimens from HIV-1-infected patients. Correlations of log-transformed HIV-1 RNA and proviral DNA concentrations with those found by reference methods were, respectively, 0.88 and 0.80. The between-run coefficients of variation for the detection method were < or = 25% (range, 9.1 to 24.7) and < or = 15% (range, 10.9 to 15.1), respectively, for HIV-1 RNA and proviral DNA. The reproducibility of the overall procedure for HIV-1 RNA in plasma (including sample preparation, amplification, and detection) was given by a duplicate standard deviation of log10 copies per ml of 0.11. Thus, the method was sufficiently precise to allow the detection of fourfold changes in plasma HIV-1 RNA concentrations, with a power of 0.95.
对血浆中1型人类免疫缺陷病毒(HIV-1)RNA以及外周血单个核细胞(PBMC)中前病毒DNA进行定量检测,可为HIV-1感染状况提供有价值的信息。本文描述了使用市售材料和酶联免疫吸附测定仪来检测分光光度变化所进行的检测。样本包括100微升血浆或200,000个PBMC。该过程包括样本制备、使用引物对SK39(5'端生物素化)和SK38进行基于PCR的扩增、将cDNA PCR产物与RNA探针杂交、通过链霉亲和素在固相上捕获RNA-DNA杂交体、与针对RNA-DNA杂交体的碱性磷酸酶偶联抗体结合以及与对硝基苯磷酸孵育。在20小时内分四个时间间隔记录分光光度变化。每次检测中纳入HIV-1 RNA或前病毒DNA标准品是该过程不可或缺的一部分。这些检测方法的动态范围——每毫升500至100万个RNA拷贝以及每10(6)个PBMC中10至5000个前病毒DNA拷贝——适用于大多数血浆标本以及所有来自HIV-1感染患者的PBMC标本。经对数转换的HIV-1 RNA和前病毒DNA浓度与参考方法所测浓度的相关性分别为0.88和0.80。HIV-1 RNA和前病毒DNA检测方法的批间变异系数分别≤25%(范围为9.1至24.7)和≤15%(范围为10.9至15.1)。血浆中HIV-1 RNA总体检测过程(包括样本制备、扩增和检测)的重复性通过每毫升log10拷贝数的重复标准差0.11来体现。因此,该方法足够精确,能够检测出血浆HIV-1 RNA浓度四倍的变化,检验效能为0.95。